Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (381-390 of 573) with videos related to

Pageof 58
Sort By:
Bone Marrow Transplantation|January 1, 1991
BAVC regimen in CR AML patientsG Meloni, M Vignetti, P De Fabritiis, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Annals of Hematology|March 1, 1997
Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's diseaseR Maurizi Enrici, A P Anselmo, M F Osti, et al.
Scandinavian Journal of Haematology|October 1, 1979
Acute non lymphoid leukaemia following Hodgkin's disease. Clinical, biological and cytogenetic aspects of 3 casesG Papa, G Alimena, L Annino, et al.
Leukemia|January 1, 1991
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomasS Tura, F Mandelli, P Mazza, et al.
Haematologica|March 1, 1990
Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemiaR Leone, F Lo Coco, G De Rossi, et al.
Bone Marrow Transplantation|July 22, 1999
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cellsP de Fabritiis, M Gonzalez, G Meloni, et al.
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.
Anticancer Research|March 26, 2002
Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): results of prospective study with multimodality therapeutic approachV De Sanctis, M Martelli, A P Anticoli, et al.
Pageof 58

Showing results (381-390 of 573) with videos related to

Sort By:
Pageof 58
Bone Marrow Transplantation|January 1, 1991
BAVC regimen in CR AML patientsG Meloni, M Vignetti, P De Fabritiis, et al.
Leukemia|January 1, 1992
Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findingsR Foa, G Meloni, A Guarini, et al.
British Journal of Haematology|May 1, 1990
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid originR Foa, P Caretto, M T Fierro, et al.
Annals of Hematology|March 1, 1997
Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's diseaseR Maurizi Enrici, A P Anselmo, M F Osti, et al.
Scandinavian Journal of Haematology|October 1, 1979
Acute non lymphoid leukaemia following Hodgkin's disease. Clinical, biological and cytogenetic aspects of 3 casesG Papa, G Alimena, L Annino, et al.
Leukemia|January 1, 1991
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomasS Tura, F Mandelli, P Mazza, et al.
Haematologica|March 1, 1990
Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemiaR Leone, F Lo Coco, G De Rossi, et al.
Bone Marrow Transplantation|July 22, 1999
Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cellsP de Fabritiis, M Gonzalez, G Meloni, et al.
Leukemia & Lymphoma|November 1, 1995
MEC (mitoxantrone, etoposide and intermediate dose cytarabine): an effective induction regimen for previously untreated acute non-lymphocytic leukemiaG Visani, M C Petti, A Cenacchi, et al.
Anticancer Research|March 26, 2002
Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): results of prospective study with multimodality therapeutic approachV De Sanctis, M Martelli, A P Anticoli, et al.
Pageof 58